Omni Pharmaceuticals Overview
- Year Founded
-
2011

- Status
-
Private
- Latest Deal Type
-
Series D
- Investors
-
11
Omni Pharmaceuticals General Information
Description
Manufacturer of generic and branded pharmaceuticals designed to focus on chronic diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma. The company's generic and branded pharmaceuticals which include inhalation dry powder, nasal and HFA aerosol and sustained release capsules and tablets are featured in drug delivery systems that are difficult to develop, manufacture, and replicate for regulated markets and for the China market, enabling regulated markets of North America, Europe and China to contribute their expertise and solve selected public health challenges.
Contact Information
- Room 2915-2916, Gong Shang Lian Building
- 55 Yan An Road (East), Huangpu District
- Shanghai, 201203
- China
Omni Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series D) | 27-Dec-2021 | 000.00 | Completed | Generating Revenue | ||
3. Later Stage VC (Series C) | 01-Oct-2017 | 000.00 | 000.00 | Completed | Generating Revenue | |
2. Early Stage VC (Series B) | 22-Sep-2015 | Completed | Startup | |||
1. Early Stage VC (Series A) | 01-Mar-2013 | Completed | Startup |
Omni Pharmaceuticals Comparisons
Industry
Financing
Details
Omni Pharmaceuticals Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mankind Pharma | Formerly PE-Backed | New Delhi, India | 00000 | 00000 | 00000000 | 00000 |
00000000 | Corporation | Berkeley Heights, NJ | 00 | 000.00 | 00000000 | 000.00 |
00000 | Corporation | Mumbai, India | 00000 | 000000000 | ||
00000000 | Corporation | Basel, Switzerland | 000000 | 0000 | 000000000 | 0000 |
000000 | Corporation | Paris, France | 00000 | 00.00 | 000000000 | 00.00 |
Omni Pharmaceuticals Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Kai Zhang Ph.D | Co-Founder & Chairman | ||
Shaochuan Zeng | Co-Founder & Chief Operating Officer |
Omni Pharmaceuticals Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Kai Zhang Ph.D | Omni Pharmaceuticals | Co-Founder & Chairman | 000 0000 |
Omni Pharmaceuticals Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bank of China Group Investment | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Origins Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Shanghai Healthcare Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Shanghai Zhangjiang Science & Technology Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
SIIC Holdings | Government | Minority | 000 0000 | 000000 0 |